Convergent Synthesis and Anti‐Pancreatic Cancer Cell Growth Activity of a Highly Branched Heptadecasaccharide from Carthamus tinctorius. (4th July 2022)
- Record Type:
- Journal Article
- Title:
- Convergent Synthesis and Anti‐Pancreatic Cancer Cell Growth Activity of a Highly Branched Heptadecasaccharide from Carthamus tinctorius. (4th July 2022)
- Main Title:
- Convergent Synthesis and Anti‐Pancreatic Cancer Cell Growth Activity of a Highly Branched Heptadecasaccharide from Carthamus tinctorius
- Authors:
- Hu, Chaoyu
Wu, Shengjie
He, Fei
Cai, Deqin
Xu, Zhuojia
Ma, Wenjing
Liu, Yating
Wei, Bangguo
Li, Tiehai
Ding, Kan - Abstract:
- Abstract: Bioactive polysaccharides from natural resources target various biological processes and are increasingly used as potential target molecules for drug development. However, the accessibility of branched and long complex polysaccharide active domains with well‐defined structures remains a major challenge. Herein we describe an efficient first total synthesis of a highly branched heptadecasaccharide moiety of the native bioactive galectin‐3‐targeting polysaccharide from Carthamus tinctorius L. as well as shorter fragments of the heptadecasaccharide. The key feature of the approach is that a photo‐assisted convergent [6+4+7] one‐pot coupling strategy enables rapid assembly of the heptadecasaccharide, whereby a photoremovable o ‐nitrobenzyl protecting group is used to generate the corresponding acceptor for glycosylation in situ upon ultraviolet radiation. Biological activity tests suggest that the heptadecasaccharide can target galectin‐3 and inhibit pancreatic cancer cell growth. Abstract : The first total synthesis of a highly branched heptadecasaccharide moiety of the native bioactive galectin‐3‐targeting polysaccharide from Carthamus tinctorius has been accomplished via a photo‐assisted convergent [6+4+7] one‐pot coupling strategy. This work demonstrates a representative example to explore potential active domains of the polysaccharide for structure–activity relationship studies, thereby facilitating pharmaceutical development.
- Is Part Of:
- Angewandte Chemie. Volume 134:Number 32(2022)
- Journal:
- Angewandte Chemie
- Issue:
- Volume 134:Number 32(2022)
- Issue Display:
- Volume 134, Issue 32 (2022)
- Year:
- 2022
- Volume:
- 134
- Issue:
- 32
- Issue Sort Value:
- 2022-0134-0032-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-07-04
- Subjects:
- Antitumor Agents -- Carbohydrates -- Glycosylation -- Oligosaccharides -- Total Synthesis
Chemistry -- Periodicals
540 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/ange.202202554 ↗
- Languages:
- English
- ISSNs:
- 0044-8249
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0902.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22768.xml